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Abstract 
Type 2 diabetes mellitus is a chronic metabolic disease that results from defects in insulin secretion 
and insulin receptor kinase. Investigation of novel small active molecule that can 
potentiate insulin action or having a similar action as insulin is important in the treatment of 
diabetes. World ethnobotanical information on medicinal plants reports almost 800 plants used 
in the treatment of diabetes mellitus. However, only a small number of them have been studied 
thoroughly. Recent study conducted on Cinnamomum reported that it has a great activity 
in activating insulin receptor kinase and inhibiting insulin receptor phosphatase leading to increased 
insulin sensitivity and function as a mimetic for insulin. Our study was designed to investigate 
insulin-mimetic activity of cinnamtannin B1 isolated from Cinnamomum zeylanicum on adipocyte 
cells. The insulin-mimetic activity of cinnamtannin B1 was evaluated by monitoring preadipocytes 
differentiation, glucose uptake and phosphorylation of insulin receptor -subunit in 3T3-L1 
adipocytes. To determine whether cinnamtannin B1 able to promote differentiation of 
preadipocytes, we cultured 3T3-L1 preadipocytes in the presence of cinnamtannin B1, or 
combination of cinnamtannin B1 and insulin, and then cell proliferation was measured at several 
points during the course of growth. Investigation of role of cinnamtannin B1 on tyrosine 
posphorylation of insulin receptor of 3T3-L1 cells was done by immunoprecipitation of cells lysate 
with anti-insulin receptor -subunit antibody and the immunocomplex samples were subjected to 
SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted with monoclonal anti- 
phosphotyrosine antibody. Evaluation of glucose uptake by adipocyte cells after treatment with 
cinnamtannin B1 was carried out by analyzing of radioactive glucose uptake with liquid scintillation 
counter. Based on these experiments, it was found that, a mixture cinnamtannin B1 with 
differentiation cocktail was able to induce differentiation of preadipocytes cells. Cinnamtannin B1 
was found to active to stimulate phosphorylation of insulin receptor -subunit by positively 
exhibited phosphorylation at 170-kDa. The mixture of cinnamtannin B1 was also able to stimulate 
glucose uptake from a basal value. The results demonstrated that activity of cinnamtannin B1 on 
adipocyte cells was found to mimicking insulin action. It acted directly on insulin receptor -subunit 
by activation of PI3-kinase that stimulates glucose transporter-4 (GLUT-4) translocation. 
Stimulation of GLUT4 translocation therefore stimulates glucose uptake lead to glucose disposal 
process in adipocytes. Based on the work that has been carried out, it was suggested that 
cinnamtannin B1 could be one of the potential lead drug compound in the treatment of type 2 
diabetes. 
